Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. Schizophrenia Drug Meet Phase III Trial Goals
2/28/2012 7:06:24 AM
More...
|
Forest Laboratories, Inc. (FRX) and Gedeon Richter Ltd. Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder
10/5/2011 6:58:07 AM
More...
|
Forest Laboratories, Inc. (FRX) and Gedeon Richter Ltd. Announce Results from a Phase II Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
2/28/2011 9:04:17 AM
More...
|
Gedeon Richter Ltd. Forms China JV with Marketing Partner
12/22/2010 9:37:54 AM
More...
|
Watson Pharmaceuticals, Inc. (WPI) and Gedeon Richter Ltd. Announce Exclusive License Agreement with PregLem SA for Esmya(TM); Watson to pay PregLem $17M
12/16/2010 6:39:38 AM
More...
|
Gedeon Richter Ltd. Buys Grunenthal GmbH Contraceptive Business for EUR 236.5 Million ($329.8 Million) Cash
11/4/2010 7:54:44 AM
More...
|
Ipsen Sells its Shares in PregLem SA to Gedeon Richter Ltd.
10/11/2010 12:21:14 PM
More...
|
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. May Do Additional Phase II Cariprazine Trial; Drug Misses Overall Goal
8/30/2010 8:06:42 AM
More...
|
Forest Laboratories, Inc. (FRX), Gedeon Richter Ltd. Say Phase 2 Diabetic Pain Drug Test Ineffective
6/29/2010 6:38:15 AM
More...
|
Forest Laboratories, Inc. (FRX) (JOBS) and Gedeon Richter Ltd. Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
10/29/2009 6:37:56 AM
More...
|
|